Wedmont Private Capital acquired a new position in shares of Albemarle Co. (NYSE:ALB – Free Report) in the third quarter, Holdings Channel.com reports. The institutional investor acquired 2,233 shares of the specialty chemicals company’s stock, valued at approximately $233,000.
A number of other large investors have also added to or reduced their stakes in the stock. Sage Capital Advisors llc increased its holdings in Albemarle by 1.5% during the third quarter. Sage Capital Advisors llc now owns 14,520 shares of the specialty chemicals company’s stock worth $1,375,000 after buying an additional 219 shares during the last quarter. Leibman Financial Services Inc. increased its holdings in Albemarle by 69.2% during the third quarter. Leibman Financial Services Inc. now owns 25,889 shares of the specialty chemicals company’s stock worth $2,452,000 after buying an additional 10,587 shares during the last quarter. Marion Wealth Management increased its holdings in Albemarle by 27.8% during the third quarter. Marion Wealth Management now owns 14,217 shares of the specialty chemicals company’s stock worth $1,346,000 after buying an additional 3,094 shares during the last quarter. Mather Group LLC. increased its holdings in Albemarle by 302.9% during the third quarter. Mather Group LLC. now owns 4,653 shares of the specialty chemicals company’s stock worth $441,000 after buying an additional 3,498 shares during the last quarter. Finally, Foster Group Inc. boosted its position in Albemarle by 7.8% during the third quarter. Foster Group Inc. now owns 3,286 shares of the specialty chemicals company’s stock worth $311,000 after purchasing an additional 239 shares during the period. Hedge funds and other institutional investors own 92.87% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of brokerages have weighed in on ALB. Wells Fargo & Company increased their target price on shares of Albemarle from $100.00 to $110.00 and gave the stock an “equal weight” rating in a research report on Tuesday, October 8th. UBS Group cut their target price on shares of Albemarle from $124.00 to $109.00 and set a “neutral” rating for the company in a research report on Tuesday, July 9th. Hsbc Global Res upgraded shares of Albemarle to a “hold” rating in a research report on Wednesday, July 17th. JPMorgan Chase & Co. cut their target price on shares of Albemarle from $115.00 to $78.00 and set a “neutral” rating for the company in a research report on Monday, August 19th. Finally, Robert W. Baird lowered shares of Albemarle from an “outperform” rating to a “neutral” rating and cut their target price for the stock from $102.00 to $85.00 in a research report on Monday, August 5th. Two analysts have rated the stock with a sell rating, fifteen have issued a hold rating and seven have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $117.60.
Albemarle Trading Down 0.9 %
Shares of Albemarle stock opened at $102.02 on Monday. Albemarle Co. has a 1 year low of $71.97 and a 1 year high of $177.52. The firm has a market cap of $11.99 billion, a PE ratio of 37.10, a PEG ratio of 13.81 and a beta of 1.54. The company has a debt-to-equity ratio of 0.38, a current ratio of 2.67 and a quick ratio of 1.75. The company has a 50 day simple moving average of $88.03 and a two-hundred day simple moving average of $103.88.
Albemarle (NYSE:ALB – Get Free Report) last posted its quarterly earnings results on Wednesday, July 31st. The specialty chemicals company reported $0.04 EPS for the quarter, missing the consensus estimate of $0.53 by ($0.49). The business had revenue of $1.43 billion for the quarter, compared to analysts’ expectations of $1.34 billion. Albemarle had a positive return on equity of 6.38% and a negative net margin of 6.72%. The company’s revenue was down 39.7% compared to the same quarter last year. During the same period last year, the business posted $7.33 earnings per share. Analysts expect that Albemarle Co. will post 0.46 earnings per share for the current fiscal year.
Albemarle Increases Dividend
The firm also recently declared a quarterly dividend, which was paid on Tuesday, October 1st. Shareholders of record on Friday, September 13th were paid a dividend of $0.405 per share. The ex-dividend date of this dividend was Friday, September 13th. This is an increase from Albemarle’s previous quarterly dividend of $0.40. This represents a $1.62 annualized dividend and a dividend yield of 1.59%. Albemarle’s dividend payout ratio (DPR) is 58.91%.
Albemarle Profile
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.
Read More
- Five stocks we like better than Albemarle
- Golden Cross Stocks: Pattern, Examples and Charts
- Why Fastenal Stock Could Hit New Highs After Strong Q3 Results
- Why is the Ex-Dividend Date Significant to Investors?
- Why Eli Lilly Stock Is Soaring—and How It Plans to Stay on Top
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- 3 Mid-Cap Stocks Under $20 With Insider Buying and Major Upside
Want to see what other hedge funds are holding ALB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Albemarle Co. (NYSE:ALB – Free Report).
Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.